Evidence map›Paper›PMID 25114110›Full record

ArticleInfection and immunity2014

Masking of β(1-3)-glucan in the cell wall of Candida albicans from detection by innate immune cells depends on phosphatidylserine.

Sarah E Davis, Alex Hopke, Steven C Minkin, Anthony E Montedonico, Robert T Wheeler, Todd B Reynolds

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 82 citations in OpenAlex.

  1. Virulence · 2026
    Article
  2. Article
  3. Loss of Fgr41 inInfection and immunity · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Disruption tomSphere · 2024
    Article
  10. Retracing the evolution ofMicrobiology and molecular biology reviews : MMBR · 2024
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Caspofungin resistance in Candida albicans: genetic factors and synergistic compounds for combination therapies.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2022
    Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Sarah E DavisDepartment of Microbiology, University of Tennessee, Knoxville, Tennessee, USA.
Alex HopkeDepartment of Molecular and Biomedical Sciences, University of Maine, Orono, Maine, USA.
Steven C MinkinAdvanced Microscopy and Imaging Center, University of Tennessee, Knoxville, Tennessee, USA.
Anthony E MontedonicoDepartment of Microbiology, University of Tennessee, Knoxville, Tennessee, USA.
Robert T WheelerDepartment of Molecular and Biomedical Sciences, University of Maine, Orono, Maine, USA.
Todd B ReynoldsDepartment of Microbiology, University of Tennessee, Knoxville, Tennessee, USA treynol6@utk.edu.
University of Tennessee at Knoxville · USUniversity of Maine · USImaging Center · US

Funding

The Maine Biomedical Research Network (INBRE)P20GM103423 · NIGMS · MOUNT DESERT ISLAND BIOLOGICAL LAB · PI Dustin Lynn Updike · 2012 to 2026
$60.0M
WNT SIGNALING IN THE DEVELOPING GASTROINTESTINAL TRACTP20RR016463 · NCRR · MOUNT DESERT ISLAND BIOLOGICAL LAB · PI WRAY, CHRISTOPHER C · 2001 to 2011
$41.0M
Screen for phosphatidylserine synthase inhibitors: antifungals & lipid probesR01AI105690 · NIAID · UNIVERSITY OF TENNESSEE KNOXVILLE · PI REYNOLDS, TODD B · 2013 to 2015
$1.2M
Genetics and visualization of innate host response to C. albicans infection in viR15AI094406 · NIAID · UNIVERSITY OF MAINE ORONO · PI WHEELER, ROBERT T. · 2012 to 2012
$422k
Role of phosphatidylethanolamine in regulating virulence in Candida albicansF31DE022512 · NIDCR · UNIVERSITY OF TENNESSEE KNOXVILLE · PI DAVIS, SARAH ELIZABETH · 2013 to 2014
$79k
NCRR NIH HHS 5P20RR016463NCRR NIH HHS P20 RR016463NIAID NIH HHS R01 AI105690NIAID NIH HHS R15 AI094406NIAID NIH HHS R15AI094406NIDCR NIH HHS F31 DE022512NIDCR NIH HHS F31DE022512NIGMS NIH HHS 8P20GM103423NIGMS NIH HHS P20 GM103423PHS HHS 1R01AL105690
6 · The paper itself

Abstract

The virulence of Candida albicans in a mouse model of invasive candidiasis is dependent on the phospholipids phosphatidylserine (PS) and phosphatidylethanolamine (PE). Disruption of the PS synthase gene CHO1 (i.e., cho1Δ/Δ) eliminates PS and blocks the de novo pathway for PE biosynthesis. In addition, the cho1Δ/Δ mutant's ability to cause invasive disease is severely compromised. The cho1Δ/Δ mutant also exhibits cell wall defects, and in this study, it was determined that loss of PS results in decreased masking of cell wall β(1-3)-glucan from the immune system. In wild-type C. albicans, the outer mannan layer of the wall masks the inner layer of β(1-3)-glucan from exposure and detection by innate immune effector molecules like the C-type signaling lectin Dectin-1, which is found on macrophages, neutrophils, and dendritic cells. The cho1Δ/Δ mutant exhibits increases in exposure of β(1-3)-glucan, which leads to greater binding by Dectin-1 in both yeast and hyphal forms. The unmasking of β(1-3)-glucan also results in increased elicitation of TNF-α from macrophages in a Dectin-1-dependent manner. The role of phospholipids in fungal pathogenesis is an emerging field, and this is the first study showing that loss of PS in C. albicans results in decreased masking of β(1-3)-glucan, which may contribute to our understanding of fungus-host interactions.

Indexed as

Immunity, Innatebeta-GlucansCandida albicansCells, CulturedCell WallDectin-1HumansLectins, C-TypeMacrophagesNeutrophilsPhosphatidylserinesTumor Necrosis Factor-alphabeta-1,3-glucanbeta-GlucansDectin-1Lectins, C-TypePhosphatidylserinesTumor Necrosis Factor-alpha

Identifiers

PMID25114110
PMCPMC4187869
OpenAlexW2115813995

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.